Hege Hammerstad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hege Hammerstad has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Gunnar Kvalheim
Department of Cellular Therapy, The Norwegian Radium Hospital, University of Oslo, Oslo, Norway
1 shared publication - Gustav Gaudernack
Section for Cancer Immunology, Institute for Cancer Research, Oslo University Hospital-The Norwegian Radium Hospital, Oslo, Norway
1 shared publication - Silvija Jarnjak-Jankovic
Department of Pediatric Research, The National Hospital, Oslo, Norway
1 shared publication - Stein Sæbøe-Larssen
Department of cellular Therapy, Oslo University Hospital, Radiumhospitalet, Ullernchausseen 70, 0379 Oslo, Norway
1 shared publication
Latest Publications
- Open Access
- 3 July 2007
- Published by Springer Nature in BMC Cancer
- Vol. 7 (1) , 119
A full scale comparative study of methods for generation of functional Dendritic cells for use as cancer vaccines
Dendritic cells (DCs) are professional antigen-presenting cells with the ability to induce primary T-cell responses and are commonly produced by culturing monocytes in the presence of IL-4 and GM-CSF for 5–7 days (Standard DC). Recently, Dauer and co-workers presented a modified protocol for differentiation of human monocytes into mature DCs within 48 hours (Fast DC). Here we report a functional comparison of the two strategies for generation of DCs from human monocytes with adaptions for large-scale clinical use.
- 3 July 2007
- Published by Springer Nature in BMC Cancer
- Vol. 7 (1) , 119
Open AccessA full scale comparative study of methods for generation of functional Dendritic cells for use as cancer vaccines
Dendritic cells (DCs) are professional antigen-presenting cells with the ability to induce primary T-cell responses and are commonly produced by culturing monocytes in the presence of IL-4 and GM-CSF for 5–7 days (Standard DC). Recently, Dauer and co-workers presented a modified protocol for differentiation of human monocytes into mature DCs within 48 hours (Fast DC). Here we report a functional comparison of the two strategies for generation of DCs from human monocytes with adaptions for large-scale clinical use.